Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.72 CAD | -0.69% |
|
+0.53% | +10.21% |
Jul. 11 | Knight Therapeutics Announced Normal Course Issuer Bid | MT |
Jul. 11 | Knight Therapeutics Brief: Announcing Normal Course Issuer Bid | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.21% | 426M | |
+7.04% | 73.13B | |
+31.10% | 10.38B | |
+37.94% | 5.16B | |
-17.33% | 4.73B | |
+21.49% | 3.81B | |
+24.92% | 2.26B | |
-36.84% | 1.88B | |
-43.31% | 1.77B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Brief: Entering into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree (viloxazine) in Canada